Literature DB >> 29432504

A retrospective study of DRESS - drug reaction with eosinophilia and systemic symptoms.

Dorota Mehrholz1, Anna Emilia Urban2, Marta Herstowska2, Roman Nowicki1, Wiesław Cubała2, Wioletta Barańska-Rybak1.   

Abstract

OBJECTIVES: DRESS (drug reaction with eosinophilia and systemic syndrome) is qualified as hypersensitivity after drug reaction. This syndrome may occur due to any medication intake. There are three main groups of symptoms defining DRESS: skin lesions, hematological abnormalities and internal organ involvement.
METHODS: A retrospective study was performed on a group of 261 patients with drug reactions hospitalized in the Clinic of Dermatology from 2004 until 2017.
RESULTS: There were ten cases of DRESS of 261 hypersensitivity drug reactions observed in the Clinic. The drug which most frequently caused DRESS in the studied group was carbamazepine - six patients (60%). Lamotrigine was the cause of DRESS in two cases, oxycarbamazepine in one patient and dexketoprofen in one patient. The skin lesion was present in 100% patients. Mainly it was coalescing hemorrhagic rash accompanied by face edema. Eosinophilia was noticed in 80% of patients and the presence of atypical lymphocytes - in 40%. The main infiltrate organ was liver in 8 cases.
CONCLUSIONS: DRESS diagnosis should be taken into consideration especially in patients treated eith antiepileptic drugs. Early diagnosis and drug discontinuation can contribute to preventing serious complications of DRESS.

Entities:  

Keywords:  DRESS; anticonvulsants; drug eruptions

Mesh:

Substances:

Year:  2017        PMID: 29432504     DOI: 10.12740/PP/74358

Source DB:  PubMed          Journal:  Psychiatr Pol        ISSN: 0033-2674            Impact factor:   1.657


  2 in total

1.  Three cases of drug-induced hypersensitivity syndrome associated with mRNA-based coronavirus disease 2019 vaccines.

Authors:  Ayumi Korekawa; Koji Nakajima; Karen Fukushi; Hajime Nakano; Daisuke Sawamura
Journal:  J Dermatol       Date:  2022-03-03       Impact factor: 3.468

2.  Quality of Life of Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) and Stevens-Johnson Syndrome (SJS) and/or Toxic Epidermal Necrolysis (TEN) Patients.

Authors:  Dyah Aryani Perwitasari; Sri Awalia Febriana; Ratna Septi Tristiana
Journal:  Patient Prefer Adherence       Date:  2021-02-15       Impact factor: 2.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.